Not Yet Recruiting
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance
NCT07313202
- Conditions
- Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
- Locations
-
Not specified